ORY.MC
Oryzon Genomics SA
Price:  
2.71 
EUR
Volume:  
884,222.00
Spain | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORY.MC Probability of Bankruptcy

The Probability of Bankruptcy of Oryzon Genomics SA (ORY.MC) is -% . This number represents the probability that ORY.MC will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating ORY.MC's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

ORY.MC - ESG ratings

ESG ratings are directly linked to the cost of capital and ORY.MC's ability to raise funding, both of which can significantly affect the probability of Oryzon Genomics SA going bankrupt.

ESG Score 88.96
Environment Score 98.66
Social Score 99.00
Governance Score 69.22
Returns
Historical Returns (5 day) 1.69%
Historical Returns (MTD) 3.05%
Historical Returns (YTD) 93.21%
Historical Returns (13 week) 86.55%
Historical Returns (26 week) 64.14%
Historical Returns (52 week) 33.25%
Efficiency
Asset Turnover
Receiveable Turnover -
Gross Margin
Operating Margin
Pretax Margin
Net Margin
Return on Asset (ROA) -3.36
Return on Equity (ROE) -4.28
Return on Investments (ROI) -3.71
Price Metrics
Market Cap (M) 212.48
Enterprise Value (M)
52 Week High 3.69
52 Week Low 1.40
Beta 0.72
Average Volume (10 day) 0.95
Average Volume (3 month) 1.00
Price / Earnings (P/E)
Price / Sales (P/S)
Earnings
EPS -0.06
Revenue CAGR (5 year)
Risk
Current Ratio 0.75
Quick Ratio 0.74